Whereas previous studies have associated SUSD2 suppression with promoter hypermethylation 26, we revealed a significant increase in SUSD2 expression in bladder cancer tissue relative to in adjacent normal tissues, indicating other regulatory mechanisms, such as dysregulated signaling or miRNA involvement. This evidence concerns the gene SUSD2 and urinary bladder cancer.